Tyson Foods Agrees to $82.5 Million Settlement in Beef Price-Fixing Case
Tyson Foods has agreed to pay $82.5 million to settle a class-action lawsuit accusing the meat giant of conspiring to inflate beef prices by restricting supply.
TRENDING TOPICS
1312 articles found for "investing"
Tyson Foods has agreed to pay $82.5 million to settle a class-action lawsuit accusing the meat giant of conspiring to inflate beef prices by restricting supply.
Former Fed Chair warns the U.S. is approaching 'fiscal dominance,' where debt financing needs could constrain the central bank's ability to fight inflation.
Federal Reserve Governor Stephen Miran argues monetary policy is 'clearly restrictive' and forecasts aggressive rate cuts ahead, diverging from other Fed officials.
The Dow Jones Industrial Average gained 595 points on January 6, 2026, closing at 48,977 for its second consecutive record as financial and energy stocks led the advance.
With the January 27-28 FOMC meeting approaching, markets expect the Federal Reserve to hold rates steady as officials assess recent economic data and prepare for potential leadership changes.
LG unveiled its first flagship Micro RGB TV at CES 2026, featuring the smallest RGB LEDs ever used in a consumer television for unprecedented brightness and color.
Dell unveils the world's first 52-inch curved 6K ultrawide monitor at CES 2026, offering 61,000 more pixels than a traditional multi-monitor setup for $2,899.
DBS Group Holdings reached a new record on January 6 as Singapore's banking giants extend their remarkable rally, offering 6%+ dividend yields for income investors.
At CES 2026, Hyundai unveiled its aggressive AI robotics strategy with $26 billion in U.S. investments and plans to deploy 30,000 robots globally by 2028.
The Nikkei 225 surged to a record close of 52,518, powered by tech stocks and bank shares as investors ride the momentum from Wall Street's strong start to 2026.
Nvidia unveils DLSS 4.5 with 6x Dynamic Multi Frame Generation, enabling 4K path-traced gaming at 240Hz and transforming the performance landscape for PC gamers.
As Novo Nordisk launches oral Wegovy and competition intensifies in the obesity drug market, Eli Lilly faces a pivotal year with Orforglipron approval expected in Q2.